Job offersmore »
- Managing Grower - Australia
- Senior Grower - Talbotville, Ontario, Canada
- Operations Manager - Fresh Produce
- Senior Account Manager Retail - Netherlands
- Supply Allocation and Inventory Manager - Fresh Produce, Italy
- Senior Grower - Katunga, Australia
- Key Account Manager - Netherlands
- Accountmanager aardappelinkoop België / Frankrijk
- International Retail Manager - Netherlands
- Quality Assurance Team EA Region -Antwerp- Quality Supervisor, Belgium
Top 5 - yesterday
Top 5 - last week
- "We are now the only people producing the tubers hydroponically"
- Oxygen level in water: an underestimated factor in plant growth
- Bitcoin mining powers tomato greenhouse
- How the rise of Amazon will urge you to create a brand in fresh produce
- UV light provides novel method to improve crop performance and yield
Top 5 - last month
Exchange ratesmore »
Australia: THC completes Queensland R&D and cultivation facilityThe Hydroponics Company has successfully completed stage 1 of its R&D facility and growing capability in Queensland. Since October 2017, THC has increased the investment in, and focus upon, the development of the Queensland site.
The site has been developed to allow for increasing demand for high quality medicinal cannabis products in both local and export markets. Stage 1 of the development includes greenhouses for indoor cultivation and growth of medicinal cannabis, a drying and shredding facility for the initial processing of the dried plants, and an extraction laboratory for the processing of crude extract from the shredded plants.
The site will also provide an onsite laboratory for development of new strains, as well as testing and quality control of harvested products. The current site, when fully optimized, will be scalable to meet the demands of a growing market.
THC plans to vertically integrate along the industry value chain by producing a high quality, processed product that will differentiate THC from companies focused solely upon the production of medicinal cannabis as an agricultural commodity. Stage 2 of the Strategic Growth plan for THC is to further process the raw material (dry bud) into higher value medicinal cannabis oils for use in both Australian and international patients. These products will be provided to approved Australian patients through the National Access Cannabis clinics in Australia as a branded product, along with other premium products from international partners. Conversations have commenced with National Access Cannabis, Canada to supply high quality Canndeo products to supplement NAC’s existing product portfolio. As at 31 August 2017, NAC Canada had in excess of 8,500 members.
David Radford of THC states: "The Board recognises the significant contribution of the Queensland team to the growth of the business. This small team has contributed significantly to the development and submission of the licence applications to the ODC, whilst managing the build out. We look forward to being granted the manufacturing licence and final approvals in order to commence the growing and manufacturing program of high quality medicinal products”.
For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia
Publication date: 2/21/2018
Other news in this sector: